MGTX
Price
$7.51
Change
+$0.59 (+8.53%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
556.13M
35 days until earnings call
XOMAP
Price
$25.58
Change
-$0.37 (-1.43%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

MGTX vs XOMAP

Header iconMGTX vs XOMAP Comparison
Open Charts MGTX vs XOMAPBanner chart's image
MeiraGTx Holdings
Price$7.51
Change+$0.59 (+8.53%)
Volume$28.15K
Capitalization556.13M
XOMA
Price$25.58
Change-$0.37 (-1.43%)
VolumeN/A
CapitalizationN/A
MGTX vs XOMAP Comparison Chart in %
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. XOMAP commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a StrongBuy and XOMAP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (MGTX: $6.92 vs. XOMAP: $25.95)
Brand notoriety: MGTX and XOMAP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 106% vs. XOMAP: 77%
Market capitalization -- MGTX: $556.13M vs. XOMAP: $0
MGTX [@Biotechnology] is valued at $556.13M. XOMAP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileXOMAP’s FA Score has 1 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • XOMAP’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAP is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 6 TA indicator(s) are bullish while XOMAP’s TA Score has 4 bullish TA indicator(s).

  • MGTX’s TA Score: 6 bullish, 5 bearish.
  • XOMAP’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both MGTX and XOMAP are a good buy in the short-term.

Price Growth

MGTX (@Biotechnology) experienced а +5.81% price change this week, while XOMAP (@Biotechnology) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

MGTX is expected to report earnings on Aug 07, 2025.

XOMAP is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX YTD gains are higher at: 13.629 vs. XOMAP (4.567). XOMAP has higher annual earnings (EBITDA): 6M vs. MGTX (-141.78M). XOMAP has more cash in the bank: 92.6M vs. MGTX (66.5M). MGTX has less debt than XOMAP: MGTX (80.9M) vs XOMAP (114M). MGTX has higher revenues than XOMAP: MGTX (34.5M) vs XOMAP (13M).
MGTXXOMAPMGTX / XOMAP
Capitalization556MN/A-
EBITDA-141.78M6M-2,363%
Gain YTD13.6294.567298%
P/E RatioN/AN/A-
Revenue34.5M13M265%
Total Cash66.5M92.6M72%
Total Debt80.9M114M71%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGTXXOMAP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
11%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
28%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
16%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
7%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QCSGX20.580.17
+0.83%
Federated Hermes MDT Small Cap Growth C
JLVRX20.970.08
+0.38%
JPMorgan Large Cap Value R5
TEOJX9.57N/A
N/A
Transamerica Emerging Markets Eq I2
UIVMX12.47N/A
N/A
MFS Intrinsic Value R1
PHLCX11.82N/A
N/A
PGIM Jennison Health Sciences C

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with AURA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+6.79%
AURA - MGTX
52%
Loosely correlated
+3.19%
IDYA - MGTX
50%
Loosely correlated
+3.79%
KRRO - MGTX
49%
Loosely correlated
+3.09%
RGNX - MGTX
49%
Loosely correlated
+4.74%
ARCT - MGTX
48%
Loosely correlated
+5.00%
More

XOMAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAP has been loosely correlated with AMLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMAP jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAP
1D Price
Change %
XOMAP100%
+0.12%
AMLX - XOMAP
51%
Loosely correlated
+2.57%
CGEN - XOMAP
31%
Poorly correlated
+0.58%
XOMAO - XOMAP
28%
Poorly correlated
+0.55%
MGTX - XOMAP
26%
Poorly correlated
+6.79%
NRXP - XOMAP
25%
Poorly correlated
+5.11%
More